Patient-Reported Outcomes Instruments Need Validation Before Pivotal Trials

Patient-reported outcomes instruments should be validated prior to use in a pivotal clinical trial, FDA Antimicrobial Drug Development & Resistance Initiatives Lead Medical Officer John Powers told a Drug Information Association webinar on FDA's PRO draft guidance April 5